A Phase 2b Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of NEOD001 in Subjects with Light Chain (AL) Amyloidosis who were previously enrolled in Study NEOD001-201 (Pronto) previously enrolled in Study NEOD001-201 (PRONTO)
Clinical Trial Grant
Awarded By
Prothena Therapeutics Limited
Start Date
October 13, 2017
End Date
June 22, 2018
Awarded By
Prothena Therapeutics Limited
Start Date
October 13, 2017
End Date
June 22, 2018